GL1X · GenesisL1 explorer

MolNFT v1 · #108061 · protein

Discovery of pyrimidine isoxazoles inha in complex with compound 15

4UVG · Enoyl-[acyl-carrier-protein] reductase [NADH]: “Discovery of pyrimidine isoxazoles inha in complex with compound 15”. X-ray diffraction, 3 ligands (NAD, A0C, MG), 2 pockets (best druggability 0.78). MolNFT v1 #108061 on GenesisL1…

PDB
4UVG
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
M9TGV3
Ligands
NAD, A0C, MG
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein26846% helix, 16% strandM9TGV3

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • A0C · 5-[(4,6-dimethylpyrimidin-2-yl)sulfanylmethyl]isoxazole-3-carboxamide · ligand · chains A
  • MG · Magnesium ion · metal · chains A
  • 1PE · Pentaethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16020.780.8345NAD, A0C
2910.400.7713empty

Compared structures

  • 4UVG · Discovery of pyrimidine isoxazoles InhA in complex with compound 15 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.